"Maintaining a balance of the probiotic system in the 7 entry points of the body to protect health and wellness."
LiveSpo is a brand focusing only on R&D, manufacturing, and distribution brand of Spobiotics (probiotics in spore form) for digestive and respiratory health, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for "A Future Without Antibiotics".
We explore the latest technological advancements and probiotics' effects on human healthy. We delve into emerging innovations' ethical and social implications, aiming to shed light on their potential benefits.
LiveSpo's spore probiotic products help support the treatment of antibiotics and increase the effectiveness of treatment from 10% to 90%. In some specific cases, they can be used as a replacement for antibiotics.
Beneficial effects of spore probiotics are driven by Unique Characteristics of Bacillus strains. Explore 6 breakthrough in LiveSpo Probiotics and our technologies after 13 years research & development.
Spobiotic Research Center (Spobiotic Center) was established on May 18th, 2022 under the fund of LiveSpo Global JSC and directly under ANABIO R&D Co., Ltd. Spobio Centre comes out into society with the aim of building an in-depth research center on spore probiotics and will be the driving force for more scientists around the world to be interested in and develop spore probiotics as a possible solution for a future without antibiotics.
On January 12th, a signing ceremony for a partnership agreement to develop and exclusively distribute LiveSpo products in the US market between LiveSpo Pharma LTD and Ameri RX Alliance LLC was held at the LiveSpo Pharma office.